Is Amazon Stock Still Worth Staking On?
Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…
Sell
14
ESPR Quote, Financials, Valuation and Earnings
Last price:
$1.70
Seasonality move
:
3.95%
Day range:
$1.60 - $1.72
52-week range:
$1.47 - $3.94
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.98x
P/B ratio:
--
Volume:
5M
Avg. volume:
3.7M
1-year change:
-19.91%
Market cap:
$334.4M
Revenue:
$332.3M
EPS (TTM):
-$0.25
ESPR Analysts' Consensus Rating
The 5 analysts providing 12-month price projections for Esperion Therapeutics shares anticipate an average target of $6.63, ranging from a low estimate of $2.05 to a high estimate of $16.00. This average target implies a growth of 292.38% compared to the current stock price of $1.69.
Consensus Price Target
$6.63
Highest Price Target
$16.00
Lowest Price Target
$2.05
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 2 | 3 | 3 |
| Hold | 1 | 2 | 2 |
| Sell | 0 | 0 | 0 |
| Consensus | Buy | Buy | Buy |
ESPR Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Palantir a Good Stock to Buy?
Palantir Technologies (PLTR) stock soared to its highest level in…
Why Is Sportradar Stock Going Up?
Sportradar (NASDAQ:SRAD) should be on your radar for a stock…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
